rna
genom
transcript
virus
contain
conserv
structur
motif
attract
target
small
molecul
inhibitor
viral
replic
ligand
bind
affect
conform
state
stabil
interact
viral
rna
target
play
key
role
infect
process
inhibit
viral
rna
function
small
molecul
ligand
extens
studi
human
immunodefici
viru
hiv
hepat
c
viru
hcv
provid
valuabl
insight
futur
explor
rna
target
viral
pathogen
includ
sever
respiratori
syndrom
coronaviru
sar
cov
influenza
insectborn
flavivirus
dengu
zika
west
nile
well
filovirus
ebola
marburg
review
recent
progress
discoveri
design
small
molecul
ligand
target
structur
viral
rna
motif
compact
genom
virus
offer
limit
number
protein
target
develop
antiinfect
therapi
structur
rna
element
viral
genom
transcript
potenti
expand
target
space
antivir
drug
discoveri
preced
clinic
approv
rnabind
drug
found
natur
productderiv
antibiot
includ
macrolid
tetracyclin
oxazolidinon
aminoglycosid
interact
ribosom
rna
rrna
bacteria
block
protein
synthesi
pathogen
welldefin
structur
rrna
provid
select
bind
site
antibiot
serv
paradigm
rna
recognit
small
molecul
ligand
rna
element
virus
extens
explor
potenti
drug
target
human
immunodefici
viru
hiv
hepat
c
viru
hcv
whose
genom
includ
conserv
noncod
region
ncrna
may
present
structur
bind
site
small
molecul
challeng
success
discoveri
design
compound
target
rna
discuss
previou
comprehens
review
articl
also
provid
histor
perspect
past
effort
explor
viral
rna
target
small
molecul
inhibitor
current
chapter
describ
progress
discoveri
investig
small
molecul
ligand
viral
rna
target
last
year
includ
perspect
potenti
new
viral
rna
target
yet
wide
explor
may
attract
interest
pathogen
unmet
emerg
medic
need
tabl
viral
rna
target
mani
rna
viru
genom
viral
transcript
contain
structur
conserv
noncod
element
rna
motif
may
access
select
target
druglik
small
molecul
ligand
follow
discuss
previous
valid
new
prospect
rna
target
virus
along
structur
properti
ssrna
genom
hiv
contain
multipl
regulatori
element
play
key
role
transcript
regul
revers
transcript
viral
protein
translat
nucleocytoplasm
transport
genom
dimer
virion
packag
hiv
transactiv
respons
tar
rev
respons
rre
regulatori
element
among
first
nonribosom
rna
target
investig
discoveri
small
molecul
inhibitor
potenti
hiv
rna
target
small
molecul
ligand
includ
dimer
initi
sequenc
di
packag
signal
gagpol
frameshift
site
fss
threedimension
structur
determin
hiv
rna
regulatori
element
nmr
crystallographi
studi
fig
previou
effort
target
hiv
rna
review
comprehens
tabl
sect
discuss
recent
studi
discoveri
inhibitor
target
tar
rre
rna
screen
scaffoldbas
design
transcript
fulllength
hiv
transcript
stimul
complex
mechan
involv
host
cell
factor
complex
viral
tat
protein
bound
tar
element
leader
region
viru
genom
tat
recogn
conserv
rna
stemloop
tar
flexibl
pyrimidinerich
bulg
adopt
stabl
conform
complex
viral
protein
peptid
fragment
small
molecul
ligand
structur
tar
complex
determin
nmr
reveal
rel
shallow
solventexpos
ligand
bind
site
widen
rna
major
groov
case
tatderiv
peptid
extend
termin
hairpin
loop
fig
disrupt
tattar
complex
compet
rnabind
ligand
includ
peptid
natur
product
aminoglycosid
synthet
small
molecul
block
hiv
replic
similarli
viral
rev
proteinrr
rna
complex
extens
studi
target
hiv
inhibitor
rre
sequenc
base
second
intron
viral
rna
genom
adopt
complex
secondari
structur
contain
stemloop
sliib
serv
bind
site
rev
nucleocytoplasm
export
fulllength
singli
splice
viral
transcript
depend
rev
bind
rre
contrast
tat
recogn
tar
rna
betasheet
domain
fig
rna
bind
rev
mediat
alpha
helix
insert
widen
major
groov
purinerich
intern
loop
rre
sliib
fig
packag
signal
resid
leader
hiv
genom
downstream
tar
element
direct
select
packag
unsplic
viral
rna
dimer
assembl
viru
particl
genom
dimer
initi
kiss
loop
interact
di
hairpin
requir
addit
packag
signal
stemloop
bind
viral
nucleocapsid
protein
di
explor
target
ligand
affect
viral
genom
packag
threedimension
structur
determin
di
kiss
loop
dimer
complex
aminoglycosid
ligand
fig
bound
fig
aminoglycosid
bind
site
locat
interfac
region
kiss
loop
resembl
structur
intern
loop
bacteri
ribosom
decod
site
asit
interact
rna
major
groov
residu
loop
recent
nmr
analysi
reveal
threedimension
structur
region
viral
genom
leader
contain
core
encapsid
signal
includ
di
element
gagpol
fss
regul
transit
highli
express
hiv
structur
protein
enzym
express
low
level
program
frameshift
translat
ribosom
frameshift
allow
maxim
code
content
viral
genom
give
access
overlap
read
frame
frameshift
depend
two
distinct
rna
motif
includ
slipperi
sequenc
read
frame
chang
downstream
motif
whose
rel
stabl
secondari
structur
stall
ribosom
hiv
rna
hairpin
long
gcrich
stem
serv
frameshift
motif
ligand
bind
hiv
fss
target
may
disrupt
stabil
rna
hairpin
therebi
affect
equilibrium
translat
structur
enzymat
function
viral
protein
threedimension
structur
ff
rna
complex
synthet
compound
determin
nmr
reveal
ligand
bind
along
major
groov
hairpin
stem
fig
hermann
hcv
member
genu
hepaciviru
flaviviru
famili
hcv
protein
translat
capindepend
mechan
control
intern
ribosom
entri
site
ire
untransl
region
utr
viral
ssrna
genom
hcv
ire
adopt
structur
fold
compris
four
discret
domain
play
key
role
recruit
assembl
host
cell
ribosom
rna
intern
loop
motif
subdomain
iia
serv
conform
switch
translat
initi
provid
bind
site
select
inhibitor
viral
translat
small
molecul
ligand
captur
extend
conform
rna
switch
inhibit
iresdriven
translat
discoveri
ire
bind
hcv
translat
inhibitor
studi
mechanismofact
describ
comprehens
previou
review
discuss
hcv
ire
target
fig
well
recent
describ
gquadruplex
target
c
nucleocapsid
gene
progress
discoveri
character
hcv
translat
inhibitor
outlin
sect
hcv
ire
element
recruit
ribosom
translat
start
site
viral
genom
without
involv
canonci
eukaryot
initi
factor
crucial
role
viral
propag
high
conserv
ire
rna
sequenc
clinic
isol
ncrna
element
recogn
earli
potenti
drug
target
among
first
inhibitor
iresdriven
translat
describ
phenazin
biaryl
guanidin
identifi
high
throughput
screen
report
translat
cell
ire
bind
reveal
studi
structur
featur
two
chemic
seri
suggest
compound
may
interact
rna
screen
direct
bind
viral
rna
basi
highthroughput
massspectrometri
approach
identifi
ligand
threedimension
model
ligandtarget
complex
determin
nmr
spectroscopi
ligand
shown
yellow
stick
represent
ad
tetraloop
indic
grey
pdb
viral
rna
target
small
molecul
ligand
subdomain
iia
intern
loop
hcv
ire
fig
mechan
action
studi
demonstr
compound
act
alloster
inhibitor
rna
conform
switch
investig
reveal
hcv
ire
subdomain
iia
motif
prototyp
new
class
rna
conform
switch
occur
ire
element
flaviand
picornavirus
unlik
tradit
metabolitesens
riboswitch
viral
rna
switch
structur
welldefin
ligandfre
bound
state
function
ligandrespons
pure
mechan
switch
structur
signatur
iialik
viral
switch
rna
intern
loop
flank
two
extend
helic
adopt
overal
bent
conform
absenc
bound
ligand
fig
lshape
fold
provid
scaffold
direct
ire
subdomain
iia
hairpin
toward
ribosom
e
site
interfac
small
larg
subunit
crystal
structur
determin
provid
insight
conform
state
hcv
subdomain
iia
switch
absenc
presenc
ligand
suggest
fortuit
ligand
guanosin
bind
site
lock
subdomain
iia
target
extend
conform
therebi
inhibit
ire
function
rna
complex
inhibitor
bind
deep
solventexclud
rna
pocket
resembl
ligand
interact
site
aptam
riboswitch
fig
recent
rna
gquadruplex
motif
discov
hcv
genom
may
serv
potenti
target
viral
inhibitor
conserv
guaninerich
sequenc
hcv
core
c
nucleocapsid
gene
may
transient
fold
motif
physiolog
condit
porphyrin
deriv
tetra
porphyrin
bind
fold
stabil
rna
motif
suffici
inhibit
viral
replic
translat
hcvinfect
cell
cultur
find
support
potenti
motif
hcv
new
target
antivir
recent
genomewid
studi
yeast
human
cell
suggest
motif
global
unfold
eukaryot
like
due
associ
abund
singlestrand
rnabind
protein
howev
conceiv
ligand
may
trap
guaninerich
sequenc
quadruplex
conform
therebi
affect
biolog
process
ssrna
genom
influenza
viru
contain
eight
proteincod
segment
vrna
transcrib
mrna
replic
complementari
sequenc
crna
viral
replicas
rnadepend
rna
polymeras
rdrp
recogn
partial
duplex
motif
form
hybrid
complementari
sequenc
end
vrna
segment
duplex
format
end
segment
lead
circular
vrna
produc
promot
transcript
replic
nmr
studi
reveal
rna
promot
aform
duplex
contain
noncanon
base
pair
next
uracil
base
form
bifurc
hydrogen
bond
interact
two
consecut
adenin
residu
opposit
strand
fig
structur
featur
induc
widen
hermann
rna
major
groov
promot
helix
near
polymeras
initi
site
may
provid
select
recognit
motif
small
molecul
inhibitor
influenza
viru
rna
replic
ligand
interfer
replic
bind
promot
structur
would
provid
novel
rout
develop
antiinfluenza
drug
sect
discuss
recent
studi
rna
promoterbind
ligand
sar
cov
express
viral
replicas
protein
rdrp
involv
program
frameshift
translat
ssrna
genom
ribosom
frameshift
maxim
code
content
viral
genom
regul
translat
overlap
read
frame
rna
virus
sar
cov
hiv
frameshift
translat
enabl
transit
product
highli
express
structur
protein
viral
enzym
express
low
level
ribosom
frameshift
occur
slipperi
sequenc
trigger
downstream
structur
rna
motif
stall
ribosom
frameshift
hiv
translat
trigger
stabl
rna
hairpin
explor
target
ligand
aim
stabil
disrupt
rna
fold
earlier
effort
target
hiv
frameshift
signal
summar
recent
review
sar
cov
frameshift
motif
rna
pseudoknot
recent
studi
target
small
molecul
ligand
inhibit
ribosom
frameshift
ligand
discoveri
effort
discuss
sect
insectborn
flavivirus
includ
west
nile
dengu
zika
virus
contain
ssrna
genom
unlik
member
hepaciviru
famili
eg
hcv
pathogen
reli
ire
element
translat
employ
structur
rna
motif
translat
control
replic
host
defens
suppress
tabl
conserv
structur
featur
flavivir
rna
element
suggest
might
viabl
target
select
small
molecul
ligand
interf
biolog
function
rna
beststudi
motif
among
element
replic
promot
utr
dengu
viru
denv
genom
recruit
viral
rdrp
replic
initi
viral
rdrp
bind
rna
threeway
junction
design
stemloop
sla
compris
first
nucleotid
utr
replic
denv
genom
preced
circular
complementari
sequenc
region
utr
orf
similar
influenza
viru
howev
unlik
influenza
circular
denv
genom
involv
rna
promot
motif
sla
denv
sla
discov
secondari
structur
predict
confirm
enzymat
well
chemic
probe
key
viral
rna
target
small
molecul
ligand
structur
element
denv
sla
threeway
junction
highli
conserv
differ
serotyp
clinic
isol
mutat
studi
demonstr
structur
conform
integr
sla
essenti
function
rna
promot
suggest
ligand
bind
rna
may
achiev
similar
inhibitori
effect
etiolog
agent
ebola
marburg
hemorrhag
fever
filovirus
carri
ssrna
genom
similar
insectborn
flavivirus
influenza
viru
filoviru
replic
requir
structur
rna
promot
unlik
former
virus
termini
filoviru
genom
interact
replic
chemic
probe
establish
extend
hairpin
within
first
nucleotid
filoviru
genom
serv
replic
promot
ebov
marv
repres
potenti
target
small
molecul
inhibitor
viral
replic
potenti
rna
target
filoviru
genom
occur
long
intergen
region
igr
separ
read
frame
seven
structur
viru
protein
specif
igr
propos
adopt
twoarm
stemloop
fold
includ
rna
fourway
junction
rna
hairpin
motif
potenti
target
filovirus
found
transcript
start
site
utr
viral
transcript
hairpin
loop
transcript
start
site
bind
nucleocapsid
protein
serv
antitermin
factor
utr
element
viral
transcript
deriv
igr
contain
hairpin
structur
propos
regul
transcript
translat
recent
bioinformat
analysi
ebov
genom
suggest
conserv
guaninerich
sequenc
within
l
gene
code
viral
rdrp
may
fold
gquadruplex
stabil
porphyrin
ligand
similar
motif
discov
hcv
core
gene
among
dna
virus
contain
potenti
rna
target
develop
antivir
drug
oncogen
kaposi
sarcoma
associ
herpesviru
kshv
caus
malign
aid
patient
kshvinduc
tumorigenesi
involv
viral
homolog
flice
inhibitori
protein
vflip
translat
protein
driven
structur
rna
element
contain
ire
includ
conserv
segment
nucleotid
vflip
ire
consist
independ
fold
rna
core
domain
whose
secondari
structur
determin
chemic
probe
mutat
analysi
ire
rna
togeth
seri
hairpin
motif
follow
immedi
downstream
provid
structur
welldefin
site
ligand
may
suppress
vflip
express
second
rna
target
kshv
hermann
potenti
antivir
intervent
small
molecul
ligand
conserv
hairpin
motif
act
enhanc
nuclear
retent
element
ene
ene
sequenc
terminu
polyadenyl
nuclear
pan
ncrna
abund
viral
transcript
lytic
kshv
replic
pan
essenti
compon
requir
viral
propag
whose
accumul
reli
posttranscript
stabil
depend
cisact
ene
rna
motif
ene
sequest
ci
pan
poli
tail
rna
tripl
helix
protect
ncrna
decay
lead
pan
accumul
ene
hairpin
contain
urich
intern
loop
enepoli
tripl
helix
complex
potenti
target
small
molecul
ligand
may
interfer
kshv
replic
hepat
b
viru
hbv
contain
dna
genom
replic
revers
transcript
intermedi
pregenom
rna
templat
pgrna
hbv
pgrna
sequest
togeth
polymeras
subvir
particl
prior
revers
transcript
initi
revers
transcript
requir
conserv
sequenc
termin
region
pgrna
also
involv
viru
encapsid
initi
encapsid
motif
adopt
stem
loop
structur
uridinerich
intern
loop
refer
epsilon
encapsid
signal
small
molecul
ligand
rna
motif
report
yet
rna
decoy
epsilon
sequenc
use
sequest
revers
transcriptas
therebi
provid
proofofprincipl
disrupt
pgrnapolymeras
interact
suppress
hbv
replic
follow
discuss
recent
progress
discoveri
design
small
molecul
ligand
rna
target
virus
includ
hiv
hcv
influenza
sar
cov
outlin
sect
among
rna
target
hiv
tar
element
earli
primari
focu
effort
develop
ligand
disrupt
bind
viral
tat
protein
previous
report
tarbind
inhibitor
ligand
includ
synthet
molecul
natur
product
peptid
whose
discoveri
design
summar
sever
previou
review
recent
studi
viral
rna
target
small
molecul
ligand
small
molecul
microarray
smm
screen
tar
hairpin
rna
conjug
fluoresc
dye
use
identifi
select
ligand
librari
druglik
immobil
synthet
molecul
thienopyridin
deriv
fig
identifi
hit
compound
target
affin
antihiv
activ
tlymphoblast
ec
valu
ligand
repres
new
druglik
chemotyp
compar
previous
report
tar
binder
lead
candid
develop
antivir
drug
may
emerg
futur
improv
similar
thienopyridin
deriv
anoth
recent
effort
discov
tarbind
ligand
fragment
screen
small
molecul
select
repres
molecular
motif
benefici
rna
recognit
perform
appli
fluorimetr
competit
assay
measur
ligandinduc
displac
dyelabel
tat
peptid
tar
complex
fragment
chosen
includ
hydrogen
bond
donor
amin
guanidin
amidin
well
aromat
ring
engag
stack
interact
potent
competitor
ligand
tattar
interact
identifi
fragment
screen
quinazolin
deriv
fig
inhibit
complex
format
ic
valu
proton
nmr
spectroscopi
confirm
interact
quinazolin
tar
rna
target
indic
chang
iminoproton
signal
upon
compound
titrat
ligand
emerg
fragment
screen
studi
test
cellular
activ
quinazolin
previous
report
approach
ligand
discoveri
hiv
tar
target
focus
deriv
aminophenylthiazol
term
nucleobas
previous
develop
scaffold
design
interact
au
pair
hydrogen
bond
hoogsteen
edg
adenin
set
amino
acid
dipeptid
conjug
aminophenylthiazol
scaffold
fig
test
tar
target
bind
antivir
activ
cell
cultur
sever
deriv
show
bind
tar
assay
measur
fluoresc
chang
upon
compound
titrat
termin
dyeconjug
rna
histidin
conjug
fig
select
ligand
whose
target
interact
affect
presenc
competitor
nucleic
acid
tighter
bind
lysin
deriv
fig
compromis
promiscu
bind
nucleic
acid
antivir
activ
test
nucleobas
conjug
hivinfect
human
cell
result
ic
valu
tenfold
lower
tar
bind
affin
suggest
compound
may
act
also
target
tar
structur
complex
ligand
tar
report
recent
includ
aminoglycosidebenzimidazol
conjug
nucleobaselink
aminoglycosid
nanomolar
affin
tar
rna
report
antivir
activ
cell
test
yet
hiv
rrerev
complex
target
inhibitor
mostli
explor
ligandbas
design
past
summar
preview
review
two
studi
report
small
molecul
highthroughput
screen
howev
effort
result
confirm
inhibitor
revrr
complex
also
show
antivir
activ
cell
recent
research
suggest
posttranscript
modif
rre
adenin
base
sliib
may
play
key
role
activ
rrerev
complex
indic
authent
model
system
requisit
studi
rna
target
bind
competit
screen
inhibitor
rrerev
interact
use
identifi
inhibitor
hiv
rna
biogenesi
around
fdaapprov
drug
test
abil
block
complex
format
rre
sliib
rna
fluoresc
dyeconjug
rev
peptid
two
drug
clomiphen
cyproheptadin
fig
identifi
inhibitor
hiv
transcript
affect
level
splice
versu
unsplic
viral
transcript
shown
clomiphen
approv
select
estrogen
receptor
modul
bound
rre
sliib
rna
k
antivir
activ
ec
valu
cell
cyproheptadin
use
antihistamin
receptor
antagonist
bound
rre
rna
k
inhibit
viral
replic
ec
valu
interact
clomiphen
rre
rna
target
specif
target
bind
cyproheptadin
compromis
presenc
competitor
nucleic
acid
interact
site
drug
rre
target
investig
nmr
reveal
grich
intern
loop
lower
stem
sliib
rna
bind
site
region
overlap
bind
site
rev
consist
propos
mechan
inhibit
competit
small
molecul
ligand
viral
protein
interestingli
compound
viral
rna
target
small
molecul
ligand
quit
hydrophob
lack
hydrogen
bond
donor
suggest
larg
number
heteroatom
hydrogen
bond
donor
acceptor
requir
confer
rna
target
properti
small
molecul
ligand
hcv
ire
subdomain
iia
rna
identifi
target
select
inhibitor
viral
translat
outlin
sect
includ
fig
diaminopiperidin
fig
ligand
initi
discov
highthroughput
massspectrometri
approach
optim
target
bind
use
structureact
relationship
data
result
inhibitor
fig
affin
k
ire
target
show
antihcv
activ
cell
cultur
ec
valu
mechan
action
studi
demonstr
compound
act
alloster
inhibitor
rna
conform
switch
subdomain
iia
fretbas
assay
develop
test
compound
abil
bind
lock
conform
subdomain
iia
lead
viral
translat
inhibit
therebi
identifi
inhibitor
captur
ire
rna
switch
extend
state
crystal
structur
analysi
subdomain
iia
target
complex
inhibitor
reveal
ligand
bind
deep
solventexclud
pocket
rna
structur
characterist
depth
complex
ligand
bind
pocket
suggest
druglik
inhibitor
may
develop
target
rna
select
inhibitor
hcv
translat
differ
fluoresc
assay
reli
fret
use
identifi
diaminopiperidin
fig
ligand
hcv
ire
lock
rna
conform
switch
bent
state
therebi
inhibit
viral
translat
initi
abund
polar
group
render
diaminopiperidin
hydrophil
compound
whose
bind
affin
subdomain
iia
rna
decreas
presenc
salt
includ
physiolog
concentr
sodium
magnesium
discoveri
optim
structur
mechan
action
studi
diaminopiperidin
hcv
translat
inhibitor
comprehens
review
recent
attempt
optim
synthesi
inhibitor
requir
lengthi
rout
construct
pyran
ring
design
secondgener
ligand
ire
subdomain
iia
target
synthes
aryl
deriv
steric
hindranc
aryl
substitu
induc
nonplanar
conform
result
compound
address
basic
ligand
increas
overal
charg
inhibitor
physiolog
condit
replac
imidazol
ring
less
basic
oxazol
ring
obtain
compound
neither
aryl
benzimidazol
oxazol
affin
iia
rna
target
better
origin
fig
base
find
fortuit
ligand
guanosin
bind
site
subdomain
iia
rna
switch
explor
aminoquinazolin
deriv
druglik
scaffold
develop
ligand
hcv
ire
target
closer
analysi
ligand
bind
site
subdomain
iia
led
us
design
aminoquinazolin
fragment
fig
whose
spirocyclopropyl
modif
target
small
pocket
backsid
inhibitor
interact
site
fragment
show
moder
bind
affin
hcv
ire
target
posit
impact
hydrophob
spirocyclopropyl
substitu
ligand
bind
suggest
inclus
care
place
nonpolar
group
improv
shape
complementar
promis
strategi
optim
compound
bind
rna
compar
oxazol
compound
fragment
stand
simplic
synthesi
achiev
two
step
commerci
start
materi
therebi
allow
straightforward
prepar
potent
deriv
futur
ligand
recent
describ
put
gquadruplex
motif
guaninerich
sequenc
hcv
core
gene
includ
porphyrin
deriv
pyridostatin
deriv
pdp
fig
stabil
rna
fold
suffici
inhibit
viral
replic
translat
porphyrin
use
target
dna
gquadruplex
exampl
telomer
region
cmyc
promot
recent
found
stabil
motif
ebov
genom
efficaci
studi
rodent
xenograft
tumor
model
reveal
despit
cation
natur
porphyrin
deriv
intraperiton
administr
compound
result
system
distribut
decreas
tumor
growth
presum
action
cmyc
gquadruplex
dna
target
addit
small
molecul
ligand
hcv
ire
copperbind
metallopeptid
report
recent
bind
ire
domain
propos
inhibit
viral
translat
damag
rna
metalcatalyz
cleavag
irestarget
metallopeptid
amino
acid
length
includ
cubind
glyglyhi
motif
follow
rnabind
sequenc
inhibit
hcv
cell
cultur
submicromolar
activ
rna
promot
motif
provid
initi
site
influenza
viru
replicas
propos
target
ligand
inhibit
viral
replic
aminoglycosid
antibiot
shown
bind
promot
rna
micromolar
affin
impact
promiscu
rnabind
natur
product
replic
report
recent
studi
nmr
fragment
screen
oligonucleotid
repres
rna
promot
compound
identifi
aminoquinazolin
deriv
fig
select
ligand
target
affin
model
rnaligand
complex
base
nmr
noe
distanc
constraint
suggest
bind
quinazolin
ligand
major
groov
motif
includ
bifurc
u
aa
motif
fig
nmr
model
promot
complex
show
quinazolin
interact
rna
target
close
contact
ligand
methoxi
substitu
clear
much
contribut
bind
may
attribut
hydrogen
bond
involv
ch
donor
group
weak
quit
rare
without
preced
antivir
activ
compound
differ
strain
influenza
demonstr
measur
inhibit
viru
cytopath
effect
highest
activ
achiev
ec
valu
howev
cellbas
viral
replic
assay
return
antivir
potenc
correspond
ec
valu
rang
synthesi
analog
deriv
furnish
compound
slightli
better
bind
affin
rna
promot
improv
activ
inhibitor
viral
replic
fig
howev
investig
note
direct
inhibit
viral
rdrp
may
contribut
antivir
activ
quinazolin
deriv
rna
pseudoknot
genom
sar
cov
trigger
frameshift
translat
therebi
enabl
transit
product
structur
protein
viral
enzym
propos
target
small
molecul
ligand
inhibit
ribosom
frameshift
threedimension
structur
model
rna
viral
rna
target
small
molecul
ligand
pseudoknot
use
silico
dock
identifi
fig
potenti
ligand
subsequ
test
reveal
inhibitor
sar
cov
translat
frameshift
vitro
virusinfect
cell
recent
bind
viral
pseudoknot
confirm
surfac
plasmon
reson
spr
howev
rel
weak
k
comparison
singlemolecul
unfold
sar
cov
pseudoknot
rna
absenc
presenc
suggest
ligand
bind
reduc
conform
plastic
rna
fold
turn
affect
ribosom
frameshift
abil
rna
fold
adopt
altern
conform
structur
determin
frameshift
effici
rather
thermodynam
stabil
rna
fold
impact
ribosom
paus
therefor
ligandinduc
frameshift
modul
may
partial
reli
stabil
rna
fold
previous
describ
inhibitor
hiv
translat
frameshift
may
affect
ribosom
function
promiscu
rna
bind
rather
bind
viral
genom
frameshift
signal
similarli
sar
cov
pseudoknotbind
ligand
may
interact
rna
target
well
may
explain
higher
potenc
compound
frameshift
inhibitor
cellbas
assay
compar
bind
affin
pseudoknot
rna
virus
show
high
genet
variabl
regulatori
motif
viral
transcript
rna
genom
often
conserv
clinic
isol
therefor
may
provid
potenti
drug
target
high
barrier
resist
develop
develop
small
molecul
inhibitor
challeng
structur
rna
howev
target
drugabl
ligand
select
care
evalu
rna
fold
rare
contain
deep
structur
rigid
bind
pocket
promis
target
druglik
ligand
among
viral
rna
characterist
promin
found
hcv
ire
subdomain
iia
offer
addit
advantag
target
switch
motif
whose
conform
state
may
affect
ligand
bind
deep
rna
pocket
similar
welldefin
ligand
bind
site
present
bacteri
riboswitch
explor
antibiot
target
recent
novel
class
synthet
antibacteri
compound
discov
exert
activ
unpreced
mechan
action
involv
target
bacteri
riboswitch
involv
cofactor
metabol
success
stori
antibiot
discoveri
bacteri
rna
target
set
promis
preced
ligand
discoveri
direct
viral
rna
provid
futur
therapeut
opportun
defin
target
structur
complex
particip
key
process
infect
well
high
conserv
pathogen
hermann
